Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook

Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook

Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

5 questions ESMO cancer drug data might answer

5 questions ESMO cancer drug data might answer

All the ASCO skinny: Lynparza’s pancreatic win, Amgen’s KRAS spotlight, Merck’s history-busting and more

All the ASCO skinny: Lynparza's pancreatic win, Amgen's KRAS spotlight, Merck's history-busting and more

5 novel immuno-oncology targets to know before ASCO

5 novel immuno-oncology targets to know before ASCO

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI